AKR1B1 Represses Glioma Cell Proliferation through p38 MAPK-Mediated Bcl-2/BAX/Caspase-3 Apoptotic Signaling Pathways

Yu-Kai Huang1,2,3, Kun-Che Chang1,4,5, Chia-Yang Li1

  • 1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

Insights

Aldo-keto reductase family 1 member B1 (AKR1B1) inhibits glioma cell proliferation by activating p38 MAPK signaling, influencing apoptosis. AKR1B1 may be a novel therapeutic target for glioma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Glioma, a prevalent brain tumor, exhibits complex regulatory mechanisms influencing cell proliferation and apoptosis.
  • Aldo-keto reductase family 1 member B1 (AKR1B1) is implicated in various cellular processes, but its specific role in glioma remains to be fully elucidated.
  • Understanding the molecular pathways governing glioma progression is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the regulatory role of AKR1B1 in glioma cell proliferation.
  • To determine the involvement of p38 MAPK activation in AKR1B1-mediated apoptosis signaling.
  • To explore the potential of AKR1B1 as a therapeutic target for glioma.

Main Methods:

  • Quantitative real-time PCR to assess AKR1B1 expression in glioma tissues and cell lines.
  • MTT assay and Western blot to evaluate the effects of AKR1B1 modulation and p38 MAPK inhibition on cell proliferation and apoptosis-related proteins (Bcl-2, BAX, caspase-3).
  • Annexin V-FITC/PI staining to confirm AKR1B1-induced apoptosis.

Main Results:

  • AKR1B1 expression was significantly downregulated in glioma tissues and glioblastoma cell lines.
  • AKR1B1 overexpression inhibited glioma cell proliferation, while knockdown increased it.
  • AKR1B1 induced p38 MAPK phosphorylation, leading to increased BAX and caspase-3 activity and decreased Bcl-2 expression, ultimately promoting apoptosis.

Conclusions:

  • AKR1B1 plays a critical role in regulating glioma cell proliferation and apoptosis.
  • The p38 MAPK signaling pathway is a key mediator of AKR1B1's effects on apoptosis.
  • AKR1B1 represents a promising therapeutic target for the development of novel glioma treatments.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K